Cargando…

P-037: EXPLORATION OF THE REAL-WORLD IMPACTS OF SLEEP UPON QUALITY OF LIFE IN PATIENTS WITH SICKLE CELL DISEASE

Detalles Bibliográficos
Autores principales:	O., AGRIPPA, K., SUMMERS, K., ANIE, P., TELFER, J., JAMES, E., LOW
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426793/ http://dx.doi.org/10.1097/01.HS9.0000873044.88960.53

Ejemplares similares

P131: REAL-TIME VACCINATION IMPACTS IN SICKLE CELL DISEASE: A REAL-WORLD PATIENT CASE STUDY FOR INFLUENZA AND COVID-19 VACCINATION
por: Agrippa, O, et al.
Publicado: (2022)

5609968 REAL-WORLD PATIENT-REPORTED OUTCOMES AND WEARABLE METRIC CORRELATIONS: REMOTE DAILY MONITORING FOR EXPLORATION OF QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023)

P1441: REAL-WORLD OUTCOMES AND DIGITALLY MONITORED QUALITY OF LIFE IN CRIZANLIZUMAB-TREATED PATIENTS WITH SICKLE CELL DISEASE.
por: Summers, Kim, et al.
Publicado: (2023)

5610107 LIVE OUTCOMES AND BIOMETRIC MONITORING: POTENTIAL IMPLICATIONS FOR PATIENT QUALITY OF LIFE IN SICKLE CELL DISEASE
por: Agrippa, O.A., et al.
Publicado: (2023)

P1448: CHARACTERISATION OF QUALITY OF LIFE-LINKED PATIENT-REPORTED OUTCOMES THROUGH A DIGITAL AND CONTINUOUS REMOTE MONITORING ECOSYSTEM IN SICKLE CELL DISEASE.
por: Summers, Kim, et al.
Publicado: (2023)

P037 Indigenous Australians’ conceptualisation of sleep health differs from western interpretations
por: Fatima, Y, et al.
Publicado: (2021)

P037 The Big Sleep ACT Project: Developing a Modern Dataset to Support Sleep Research
por: Malagutti, N, et al.
Publicado: (2023)

P037 Differences in endotypes in people with multiple sclerosis in those with versus without OSA
por: Sloane, J, et al.
Publicado: (2022)

P037. Headache in multiple sclerosis: prevalence and clinical features in a case control-study
por: Terlizzi, Rossana, et al.
Publicado: (2015)

P037: Nosocomial influenza prevention using multi-modal intervention strategies; 20-years of experience
por: Iten, A, et al.
Publicado: (2013)

O037 Genioglossus motor control following the return to sleep after brief arousal
por: Dawson, A, et al.
Publicado: (2021)

P.037 PCR on Dried Salivary Swab (DSS-test): a useful method for diagnosis of congenital cytomegalovirus infection?
por: Binda, S., et al.
Publicado: (2009)

5613459 PAIN IN YOUTH WITH SICKLE CELL DISEASE AND ASSOCIATION WITH SLEEP
por: Hyppolite, R.H., et al.
Publicado: (2023)

P127: HEALTHCARE RESOURCE UTILIZATION PATTERNS AND RELATED COSTS IN PATIENTS WITH SICKLE CELL DISEASE IN NORTH LEBANON- A REAL-WORLD EXPERIENCE
por: Adlette Inati, A, et al.
Publicado: (2022)

P037 Home spirometry engagement in a paediatric network post pandemic
por: Lawrence, P., et al.
Publicado: (2023)

5610417 IN-VITRO REAL-TIME OBSERVATION OF MODERATE SICKLING KINETICS IN SICKLE ERYTHROCYTES TREATED BY VOXELOTOR UNDER MONOTONIC AND CYCLIC HYPOXIA
por: Qiang, Y.Q., et al.
Publicado: (2023)

O037 Diagnostic Accuracy of OSA Screening Tools for Acute Coronary Syndrome
por: Tong, B, et al.
Publicado: (2023)

5613341 REAL-WORLD CHANGES IN KIDNEY FUNCTION FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANAEMIAS RECEIVING IRON CHELATION THERAPY IN THE US
por: Sunil Bhandari, S.B., et al.
Publicado: (2023)

T.03.7 PRELIMINARY RESULTS ON SARS-COV-2 VACCINATION RESPONSE IN PATIENTS WITH COELIAC DISEASE AND NON-COELIAC ENTEROPATHIES: A SINGLE-CENTRE CASE-CONTROL STUDY
por: Scalvini, D., et al.
Publicado: (2022)

5599344 IMPACT OF HOSPITAL ADMISSION FOR VASO-OCCLUSIVE CRISIS ON HEALTH-RELATED QUALITY OF LIFE IN CHILDREN WITH SICKLE CELL DISEASE
por: Vuong, C., et al.
Publicado: (2023)

P-089: EVALUATION OF SAFETY AND EFFICACY OF HBS-SAILIN®: A POTENT INGENIOUS ANTI-SICKLING AGENT THAT REDUCES PAIN AND IMPROVES THE QUALITY OF LIFE IN SICKLE CELL PATIENTS.
por: S., BHATT, et al.
Publicado: (2022)

O037 Understanding ventilatory control in children with Prader-Willi syndrome
por: Patoglu, O, et al.
Publicado: (2022)

P115: REAL-WORLD DATA ON THE EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS.
por: Elenga, N, et al.
Publicado: (2022)

P1497: BURDEN OF SICKLE CELL DISEASE: RESULTS FROM THE REAL WORLD ASSESSMENT SURVEY FOR SICKLE CELL DISEASE IN SAUDI (ROARS)
por: Jastaniah, W., et al.
Publicado: (2022)

5613396 DIFFERENCE IN HOSPITALIZATIONS AND ANNUAL BED DAYS FOR PATIENTS WITH SICKLE CELL DISEASE BY VARYING LEVELS OF ANEMIA: A RETROSPECTIVE ANALYSIS OF LINKED PRIMARY AND SECONDARY CARE DATABASES IN ENGLAND
por: Telfer, P., et al.
Publicado: (2023)

P-010: TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HEALTHCARE PROFESSIONAL (HCP)–PATIENT RELATIONSHIP: HCP OPINIONS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: B., ANDEMARIAM, et al.
Publicado: (2022)

5613294 BASELINE PATIENT CHARACTERISTICS FROM A UK EARLY ACCESS TO MEDICINES SCHEME (EAMS) WITH VOXELOTOR, A HBS POLYMERIZATION INHIBITOR, FOR THE TREATMENT OF HEMOLYTIC ANEMIA DUE TO SICKLE CELL DISEASE
por: Eleftheriou, P., et al.
Publicado: (2023)

O037: Prevention of Staphylococcus aureus infection in NICU: routine microbiological surveillance and decolonization
por: Richtmann, R, et al.
Publicado: (2013)

5610726 EXPERIENCE OF LIFE FOR CHILDREN AND YOUNG PEOPLE WITH SICKLE CELL DISORDERS: LESSONS LEARNED FROM A PUBLIC ENGAGEMENT EVENT
por: Pillay, K., et al.
Publicado: (2023)

P-094: EXPLORING SCHOOL LIVED EXPERIENCES OF SECONDARY STUDENTS WITH SICKLE CELL DISEASE THROUGH THEIR PARENTS’ LENS
por: C., HARDEN
Publicado: (2022)

P1432: PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE
por: Andemariam, Biree, et al.
Publicado: (2023)

5610611 REAL-WORLD EVIDENCE CHARACTERIZING THE BURDEN OF DISEASE IN ALPHA AND BETA THALASSEMIA PATIENTS IN THE USA: AN INTERIM ANALYSIS
por: Musallam, K.M., et al.
Publicado: (2023)

P1493: CHRONIC COMPLICATIONS IN THE EAST LONDON SICKLE NEWBORN COHORT STUDY (ELSNCS)
por: Sangarappillai, C., et al.
Publicado: (2022)

5613386 CELEBRATING THE SICKLE CELL DISEASE WORLD DAY ON JUNE 19TH AFTER TWO YEARS OF PANDEMIC: MY LIFE WITH SCD, PATIENTS’ PERSPECTIVE
por: Maran, J.E.M., et al.
Publicado: (2023)

P-036: PIEZO1 ACTIVATION AUGMENTS SICKLING PROPENSITY AND THE ADHESIVE PROPERTIES OF SICKLE RED BLOOD CELLS
por: N., CONRAN, et al.
Publicado: (2022)

Real-world economic impact of onabotulinumtoxina in patients with chronic migraine
por: Rothrock, JF, et al.
Publicado: (2013)

Ward outings: providing patients with meal support in the real world
por: Litchfield, Heather
Publicado: (2015)

P1485: A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
por: Andemariam, B., et al.
Publicado: (2022)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

P02.153. Effectiveness of biofield therapy for patients with sickle cell disease in Africa
por: Mikobi, M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_213c5ffva3a39vun6mtg2l2mto